Categories: aggregated

The Trillion-Dollar Question: Why Big Pharma’s Monopoly Fights to Keep Cannabis Illegal?

A recent study published in Health Economics provides a smoking gun that prohibition apologists would prefer you ignore. Researchers found that cannabis legalization reduces prescription drug spending by approximately 6% in small group insurance markets, with the effect growing stronger over time. Translation: when people can legally access cannabis, they spend less money on Big Pharma’s products.

Jason

Share
Published by
Jason

Recent Posts

Amsterdam Won’t Ban Tourists From Its Coffeeshops After All. It’s Coming For Their Wallets Instead.

The years-long push to lock foreign visitors out of the city’s coffeeshops just died in…

22 hours ago

Rappin’ The Rivers Is Building Montana’s Hip-Hop Outpost

When most people think about major hip-hop festivals, Montana rarely enters the conversation. For decades,…

22 hours ago

Five THC Cocktails For A Summer Without The Hangover

From a black currant sour to an espresso martini riff, here are five THC cocktails…

22 hours ago

Meet Micro TDH, the Venezuelan Artist Putting Older Women Smoking Weed in His Music Videos

In the music video for “Ram Pam Pam,” Venezuelan artist Micro TDH put older women…

22 hours ago

The Drink in Your Hand Was Never Just a Drink

The new cannabis beverage boom isn’t really about replacing booze. It’s about replacing everything people…

2 days ago

Cannabis Equity Was Built to Repair the War on Drugs. Its Architect Says It Funneled Black Founders Into a Trap.

Amber Senter co-founded Supernova Women, the organization that helped shape America’s first cannabis social equity…

2 days ago